Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $4.30 USD
Change Today +0.175 / 4.25%
Volume 138.0K
ACRX On Other Exchanges
As of 12:30 PM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Pamela P. Palmer M.D., Ph.D.

Co-Founder, Chief Medical Officer and Director,AcelRx Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 13 board members in 1 different organizations across 2 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. Pamela Pierce Palmer, M.D., Ph.D., has been the Chief Medical Officer of AcelRx Pharmaceuticals, Inc. since co-founded it in July 2005. Dr. Palmer serves as Director of UCSF PainCARE at Center for Advanced Research and Education. Dr. Palmer specialized clinically in treating acute and chronic pain and also is a leader in opioid and serotonin receptor research, as well as peripheral pain and inflammation mechanisms. She Co-founded Omeros Medical Systems, Inc. and ...

Read Full Background

Corporate Headquarters*

351 Galveston Drive
Redwood City, California 94063

United States

Phone: 650-216-3500
Fax: 650-216-6500

Board Members Memberships*

Co-Founder, Chief Medical Officer and Director


Stanford University
Department of Neurology and Neurological Sciences, Stanford University School of Medicine

Other Affiliations*

Annual Compensation*

Total Annual Compensation$421,000

Stock Options*

All Other Compensation$7,800
Exercisable Options785,915
Exercisable Options Value$2,434,271
Unexercisable Options494,133
Unexercisable Options Value$559,266
Total Value of Options$2,993,537
Total Number of Options1,280,048

Total Compensation*

Total Annual Cash Compensation$533,787
Total Short Term Compensation$421,000
Other Long Term Compensation$7,800
Total Calculated Compensation$1,661,309
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ACRX:US $4.30 USD +0.175


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACELRX PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at